News About: Pharm. Industry
Concerns mounting over doctors’ pledge to eradicate drug rebates
The Korean Medical Association and the Korean Academy of Medical Sciences said on Monday that they will come up with their own disciplinary measures to discourage their members from taking rebates from pharmaceutical ...
IP-K, Sanofi Aventis Korea to conduct new research collaboration to combat HBV
Hepatitis B, one of the most common and serious infectious diseases, will be targeted in a new collaborative venture between Institut Pasteur Korea (IP-K) and the Korean arm of the leading global healthcare company, S...
KPMA to challenge anti-trust watchdog
The Korea Pharmaceutical Manufacturers Association (KPMA) said Monday that it will make opposition against the Fair Trade Commission (FTC) in protest of penalties the anti-trust watchdog issued against the KPMA involv...
Daiichi Sankyo Korea, Daewoong to co-market Sevikar HCT
Daiichi Sankyo Korea and Daewoong Pharma on Monday announced that the two companies have signed an agreement to co-market Sevikar HCT tablets here.
Sevikar HCT, which contains three active ingredients, amlodipine, ...
KPMA fined for fair trade violations
The Korea Pharmaceutical Manufacturers Association (KPMA) has been fined for threatening sanctions on its member companies over their attempts to supply extremely low-priced drugs to five national hospitals under the ...
Concerns grow over punishment of fair trade violations
Korea’s incoming president, Park Geun-hye, is considering harsher penalties for anti-competitive behavior by companies as well as making it easier for prosecutors to charge them over legal violations and irregularitie...
Overheated generic battle
With many global makers' blockbuster products losing patent, the race for the generic drug market is seen to be further intensifying.
According to data by Yakup.com, a pharmaceutical information provider, the indus...
National health insurance to cover Trajenta duo
Boehringer Ingelheim Korea said Thursday that its combination form Trajenta duo (linagliptin + metformin) will be included in Korea’s health insurance from Feb. 1.
The insurance price of Trajenta duo for 2.5/1000mg...
MSD Korea promotes two executivesMSD Korea on Friday said it promoted sales and marketing director Kim Sang-pyo to an executive of U.S. based Merck & Co’s Diversified Brands Division. In addition, Oh So-yoon wa...
|
Takeda Korea eyes bigger pie in domestic OTC market
Takeda Korea plans to step up the marketing of its five-type cold remedy Hituben from March in a bid to maintain its leading status in the local cold drug market.
It will soon have a soft capsule Hituben, produced ...
